Pierre Rocheteau holds a PhD in biology and biotechnology from the Pasteur Institute and an MBA from ESCP-Europe. He has four years of experience as a business strategy consultant and four years as the director of the human care department at the Olmix Group. Since January 2021, he has founded and serves as the CEO of Olgram, a biopharmaceutical company dedicated to tackling chronic infectious diseases by targeting the pathogens responsible for their persistence.
